MARKET

BRAXF

BRAXF

Braxia Scientifi
OTCPK
0.032
-0.001
-3.03%
Closed 14:00 11/25 EST
OPEN
0.032
PREV CLOSE
0.033
HIGH
0.032
LOW
0.032
VOLUME
1
TURNOVER
0
52 WEEK HIGH
0.608
52 WEEK LOW
0.029
MARKET CAP
5.39M
P/E (TTM)
-0.6362
1D
5D
1M
3M
1Y
5Y
Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More
Alberta Becomes The First Canadian Province To Regulate Psychedelics-Assisted Therapy
Benzinga · 10/07 21:13
Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option
Being the sole psychedelic legally available as medicine, ketamine-assisted therapy services are expanding at a rapid pace across the U.S. 
Benzinga · 10/05 15:56
Braxia Scientific Announces Board Appointment
Braxia Scientific Corp. ("Braxia Scientific", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960) a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders, is ...
PR Newswire · 09/21 23:07
Great Psychedelics And Business Events Are Coming In Q4: Check Them Out Here
The season for psychedelics conferences is right around the corner. From very large and well-known events to small meets, this year’s remaining months are loaded with on-site and virtual discussions around the natural plant and synthetic medicines revolutionizing mental health.
Benzinga · 09/13 18:12
4 Psychedelics Companies Post Financial Results: Learn How Field Trip, Wesana, Braxia and Irwin Naturals Performed
Field Trip (NASDAQ: FTRP), Wesana (OTCQB: WSNAF), Braxia (OTC: BRAXF) and 
Benzinga · 08/30 19:46
Telehealth Market News: Braxia Scientific Enters Industry By Acquiring Ketamine Treatment Platform In Florida
A researcher and provider of ketamine-assisted treatments for mental health conditions, Braxia Scientific Corp.
Benzinga · 08/03 18:52
Braxia Scientific acquires Florida's mental health platform for $6.26M
Braxia Scientific (OTCPK:BRAXF) <a href="https://seekingalpha.com/pr/18889660-braxia-scientific-enters-u-...
Seekingalpha · 08/03 11:53
Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.
Braxia Scientific Corp. ("Braxia", or the "Company"), (CSE: BRAX) (OTC: BRAXF) (FSE: 4960), a leader in the treatment and research of mental health conditions, is pleased to announce it has acquired 100% of the issued and outstanding stock of KetaMD, Inc. ...
PR Newswire · 08/03 11:00
More
About BRAXF
Braxia Scientific Corp, formerly Champignon Brands Inc, is a Canada-based research driven medical solutions company. The Company focuses on owning and operating multidisciplinary clinics providing treatment for mental health disorders and research activities related to discovering and commercializing drugs and delivery methods. The Company develops ketamine and psilocybin derivatives and other psychedelic products from its Internet protocol (IP) development platform. It also operates multidisciplinary community-based clinics offering treatments for depression. Its treatments include Intravenous (IV) Ketamine, Intranasal (IN) Esketamine and Oral Ketamine Tablets.

Webull offers kinds of Braxia Scientific Corp stock information, including OTCPK:BRAXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BRAXF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BRAXF stock methods without spending real money on the virtual paper trading platform.